Millennium Management »

Cyteir Therapeutics shares owned by Millennium Management

Quarter-by-quarter ownership of Cyteir Therapeutics shares owned by Millennium Management from 13F filings

Historical chart of Millennium Management investment in Cyteir Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cyteir Therapeutics held by Millennium Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cyteir Therapeutics by Millennium Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.4M 452k 3.04
2023-06-30 $53k 21k 2.60
2023-03-31 $152k 84k 1.81
2022-12-31 $296k 179k 1.65
2022-06-30 $380k 127k 2.99
2022-03-31 $585k 155k 3.77
2021-06-30 $3.0M 138k 21.40

More positions owned by Millennium Management

Ishares Tr Russell 2000 Etf (IWM)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
NVIDIA Corporation Put Option (NVDA)
Microsoft Corporation Call Option (MSFT)
Apple (AAPL)
Meta Platforms Cl A Call Option (META)
Amazon Put Option (AMZN)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Tesla Motors Put Option (TSLA)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Ishares Tr Core S&p500 Etf (IVV)
Advanced Micro Devices Call Option (AMD)
Ishares Tr Msci Emg Mkt Etf Call Option (EEM)
Broadcom (AVGO)

View all positions for Millennium Management

Top funds holding Cyteir Therapeutics

BML Capital Management
Acadian Asset Management
Boston Family Office
Lindbrook Capital

View all funds holding Cyteir Therapeutics